Gibson, Dunn & Crutcher LLP and DLA Piper LLP have advised Brookfield Asset Management and the Canada Pension Plan Investment Board. Hogan Lovells Cadwalader US LLP...
Brookfield and CPP Investments Acquire LXP Industrial Trust in $5.2 Billion All-Cash Take-Private Deal
KKR to Acquire North American Operations and Assets of EDF Power Solutions
Gibson Dunn has advised KKR. White & Case has advised EDF power solutions S.A. KKR has entered into an agreement to acquire the operations and assets...
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Reserv Secures $125 Million in Series C Funding Led by KKR
Paul Hastings has advised Reserv Inc., and Gibson Dunn has dvised KKR as lead investor on the deal. Reserv Inc., an AI-native third-party administrator (TPA) and...
Brookfield to Acquire Peakstone Realty Trust in $1.2 Billion Take-Private Deal
Latham & Watkins LLP and O’Melveny & Myers have advised Peakstone Realty Trust. Gibson, Dunn & Crutcher LLP and Thompson Hine LLP advised Brookfield Asset Management....
Arlington Capital Partners Sells Tex-Tech Industries to Michelin
Sheppard Mullin Richter & Hampton LLP and Morrison Foerster LLP have advised Arlington Capital Partners and Tex-Tech Industries. Gibson, Dunn & Crutcher LLP and DLA Piper...
XOMA Royalty to Acquire LAVA Therapeutics in Cash and Contingent Value Rights Deal
Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V. have advised XOMA Royalty Corporation on the transaction, while Cooley LLP and NautaDutilh N.V. as its...
Polymarket Acquires QCEX in $112 Million Transaction to Enable US Market Re-Entry
Gibson Dunn has advised Polymarket. Polymarket, the world’s largest prediction market, has completed the acquisition of QCX, LLC and QC Clearing LLC, collectively known as QCEX,...
XenoTherapeutics to Acquire ESSA Pharma in All-Cash Agreement Backed by XOMA Royalty
Skadden, Arps, Slate, Meagher & Flom LLP, alongside Blake, Cassels & Graydon LLP, have advised ESSA Pharma Inc. Stikeman Elliott LLP and Gibson, Dunn & Crutcher...
Esperion Therapeutics’ Royalty Purchase Agreement with OMERS
Gibson Dunn & Crutcher advised Esperion Therapeutics, Inc. on the deal. Esperion Therapeutics, Inc. (Nasdaq: ESPR) announced that it has entered into a Royalty Purchase Agreement...